Search Results

Displaying Results 2151-2175 of 2608 "'DNA'"

Aug 19, 2025, 07:48 ET Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC

monoclonal antibodies, which is then endocytosed by tumor cells and releases KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.

More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.


Aug 19, 2025, 02:39 ET Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective

More news about: Illumina


Aug 18, 2025, 19:30 ET NEV yang Jadi Kuda Hitam Baru! LEPAS L8 Wujudkan Pengalaman Berkendara Modern dengan DNA Teknologi

multimedia:https://www.prnewswire.com/id/rilis-berita/nev-yang-jadi-kuda-hitam-baru-lepas-l8-wujudkan-pengalaman-berkendara-modern-dengan-dna-teknologi-302532747.html

More news about: Chery Group


Aug 18, 2025, 19:18 ET AccountabilIT Joins the Microsoft Intelligent Security Association

feature updates—making enterprise-grade security practical, scalable, and accessible. "At AccountabilIT, cybersecurity runs deep—it's in our DNA," said Chuck Vermillion, CEO of AccountabilIT. "Every challenge we tackle, every breakthrough our team achieves, means

More news about: AccountabilIT


Aug 18, 2025, 13:15 ET NEVのダーク・ホース!LEPAS L8が、テクノロジーのDNAで洗練されたドライビングの美学を形作る

View original content to download multimedia:https://www.prnewswire.com/jp/news-releases/nevlepas-l8dna-302532476.html SOURCE Chery Group

More news about: Chery Group


Aug 18, 2025, 09:30 ET Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify

More news about: Co-Diagnostics


Aug 18, 2025, 09:00 ET /R E P E A T -- Can-Am Breaks New Ground: Introducing the Outlander Electric, Outlander MAX 6x6, Maverick R X rc, and the First ATV with Semi-Active Suspension/

"Innovation is at the core of Can-Am's DNA," said Julie Tourville, Director, Global Marketing, Can-Am Off-Road at BRP. "The 2026 Can-Am

More news about: BRP Inc.


Aug 18, 2025, 08:30 ET Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma

curative-intent chemotherapy. MRD was measured using the Foresight CLARITY™ assay, which leverages PhasED-Seq™, a next-generation circulating-tumor DNA detection technology capable of identifying fewer than one mutant molecule per million.1 Key findings from the study include:

More news about: Foresight Diagnostics, Inc.


Aug 18, 2025, 08:30 ET Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

ALS, Alzheimer's disease, and Parkinson's disease. The Company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. KLOTHO is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical

More news about: Klotho Neurosciences, Inc.


Aug 18, 2025, 07:35 ET Skryté eso medzi NEV! LEPAS L8 formuje estetiku sofistikovanej jazdy s technologickou DNA

content:https://www.prnewswire.com/news-releases/skryte-eso-medzi-nev-lepas-l8-formuje-estetiku-sofistikovanej-jazdy-s-technologickou-dna-302532182.html

More news about: Chery Group


Aug 18, 2025, 07:29 ET Czarny koń wśród pojazdów NEV! LEPAS L8 kształtuje estetykę wyrafinowanej jazdy z technologicznym DNA

content:https://www.prnewswire.com/news-releases/czarny-ko-wrod-pojazdow-nev-lepas-l8-ksztatuje-estetyk-wyrafinowanej-jazdy-z-technologicznym-dna-302532178.html

More news about: Chery Group


Aug 18, 2025, 07:27 ET Černý kůň vozidel na novou energii! LEPAS L8 utváří estetiku sofistikovaného řízení s technologickou DNA

content:https://www.prnewswire.com/news-releases/erny-k-vozidel-na-novou-energii-lepas-l8-utvai-estetiku-sofistikovaneho-izeni-s-technologickou-dna-302532174.html

More news about: Chery Group


Aug 18, 2025, 04:51 ET NEV Dark Horse! LEPAS L8 prägt die Ästhetik des anspruchsvollen Fahrens mit technologischer DNA

LEPAS der Chery Group hat mit dem neuesten L8-Modell ein beeindruckendes Debüt auf dem internationalen Markt gefeiert. Mit seiner „Positiven Neuen Energie"-DNA integriert der L8 die globale Technologie-Matrix und die zukunftsorientierte Entwicklungsphilosophie der Chery Group und verbindet bahnbrechende

More news about: Chery Group


Aug 18, 2025, 04:33 ET Nev Dark Horse! LEPAS L8 molda a estética da condução sofisticada com DNA tecnológico

multimedia:https://www.prnewswire.com/br/comunicados-para-a-imprensa/nev-dark-horse-lepas-l8-molda-a-estetica-da-conducao-sofisticada-com-dna-tecnologico-302532074.html

More news about: Chery Group


Aug 17, 2025, 20:52 ET NEV Dark Horse! LEPAS L8 Shapes the Aesthetics of Sophisticated Driving with Technological DNA

content:https://www.prnewswire.co.uk/news-releases/nev-dark-horse-lepas-l8-shapes-the-aesthetics-of-sophisticated-driving-with-technological-dna-302531785.html

More news about: Chery Group


Aug 17, 2025, 20:23 ET NEV Dark Horse! LEPAS L8 Shapes the Aesthetics of Sophisticated Driving with Technological DNA

multimedia:https://www.prnewswire.com/news-releases/nev-dark-horse-lepas-l8-shapes-the-aesthetics-of-sophisticated-driving-with-technological-dna-302531769.html

More news about: Chery Group


Aug 17, 2025, 20:00 ET Can-Am Breaks New Ground: Introducing the Outlander Electric, Outlander MAX 6x6, Maverick R X rc, and the First ATV with Semi-Active Suspension

"Innovation is at the core of Can-Am's DNA," said Julie Tourville, Director, Global Marketing, Can-Am Off-Road at BRP. "The 2026 Can-Am

More news about: BRP Inc.


Aug 16, 2025, 10:15 ET Redefining Hospitality and Commercial Artwork Standards: A Full-Spectrum Solution for Space Art's Four Critical Pain Points

Core Strategy: Artist-Led Co-Creation 30+ In-House Artists embedded from schematic design phase, decoding brand DNA"Space-Culture-Art" Triad Framework: Each art piece becomes a tangible brand icon, transforming interiors into unique art-centric

More news about: ZhengyinArt


Aug 16, 2025, 08:41 ET Redefining Hospitality and Commercial Artwork Standards: A Full-Spectrum Solution for Space Art's Four Critical Pain Points

Core Strategy: Artist-Led Co-Creation 30+ In-House Artists embedded from schematic design phase, decoding brand DNA"Space-Culture-Art" Triad Framework: Each art piece becomes a tangible brand icon, transforming interiors into unique art-centric

More news about: ZhengyinArt


Aug 15, 2025, 11:00 ET Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™

advancements. By Method, the epigenetics market segmentation by methodology includes DNA methylation, histone modifications, and additional approaches such as non-coding RNA interactions and chromatin remodeling. The DNA methylation segment is projected to exhibit a robust compound annual growth rate (CAGR)

More news about: MarketsandMarkets


Aug 15, 2025, 09:02 ET Global DNA Forensics Market Accelerates with Growing Demand for High-Tech Investigative Solutions | 'BCC Research LLC'

Technological Advancements: Innovations in DNA testing, especially for paternity and familial relationships, have made these services faster, less expensive and more widely used. DNA Databases: Expanding national and global DNA databases helps match samples quickly, improving investigation speed

More news about: BCC Research LLC


Aug 15, 2025, 09:00 ET Reejig Brings World-First Task-Level Intelligence to Galileo, Giving Leaders the Clarity to Reinvent Work for AI

intelligence from over 130 million real jobs, and validated with billions of live work signals from the world's largest organizations - capturing the full DNA of how work is designed, executed, and evolved. This comprehensive mapping is what enables Reejig to deliver task-level intelligence - giving

More news about: Reejig


Aug 15, 2025, 08:30 ET Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®

ranging from 97% to 100%. MI Cancer Seek offers the added benefit of simultaneous RNA and DNA extraction from minimal tissue input compared to other tissue-based assays that may require individual testing processes for DNA and RNA and result in increased tissue requirements and potential delays. "MI

More news about: Caris Life Sciences


Aug 15, 2025, 06:42 ET Weekly Recap: 14 Health Press Releases You Need to See

Gene Therapy Development and Manufacturing ProBio's new capabilities offer clients fully integrated services—including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation and aseptic fill/finish—within a single U.S.-based location. This streamlined

More news about: PR Newswire


Aug 14, 2025, 21:54 ET Global Times: From mines to green hills - two generations witness 20 years of China's ecological development miracle under 'two mountains' concept

model, Li focuses on building communities. She transformed an abandoned bamboo and timber factory into a multifunctional community space, launching the "DNA (Digital Nomad Anji)" project in 2021. Programmers, designers, and creatives have moved their studios into this mountain-water setting, working

More news about: Global Times


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.